Histology
Carcinoma of Unknown Primary
CI-CAN-00002109Explore in graph →
4,151 active trials54 approved drugs532 evidence items
Loading cancer entity…
Loading cancer entity…
Histology
CI-CAN-00002109Explore in graph →
Clinical trials
14,225 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,893)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01552980 | Efficacy and Safety Study of a Modified SOX Regimen in First-Line Treatment of Unresectable Gastric Adenocarcinoma(mSOX) | unknown | Phase 2 | 30 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Mar 28, 2012 | clinicaltrials |
| NCT01095120 | Tesetaxel as Second-line Therapy for Patients With Advanced Gastric Cancer | unknown | Phase 2 | 27 | Genta IncorporatedINDUSTRY | 2 | Mar 15, 2012 |
| clinicaltrials |
| NCT01533324 | S-1/LV One Week on and One Week Off Regimen in Advanced Hepatocellular Carcinoma (HCC) | unknown | Phase 2 | 32 | Second Military Medical UniversityOTHER | 1 | Feb 15, 2012 | clinicaltrials |
| NCT01497041 | A Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line Treatment | unknown | Phase 2 | 35 | Korean South West Oncology GroupNETWORK | 1 | Dec 22, 2011 | clinicaltrials |
| NCT01276769 | Comparison Study of Neoadjuvant Paclitaxel Plus Carboplatin/Epirubicin Treatment in Triple-negative Breast Cancer | unknown | Phase 2 | 80 | Chinese Academy of Medical SciencesOTHER | 1 | Nov 16, 2011 | clinicaltrials |
| NCT01429766 | A Prospective Study of Variation in Breath Holding Times at Various Phases of Respiration During the Course of Radiotherapy Including the Effect of Respiratory Training in Lung Cancer Patients | unknown | Phase 2 | 100 | Tata Memorial HospitalOTHER_GOV | 1 | Sep 7, 2011 | clinicaltrials |
| NCT01429961 | Trial of Palliative Chemotherapy With TS-1 and Oxaliplatin for Patients With Advanced Hepatocellular Carcinoma | unknown | Phase 2 | 38 | Seoul National University HospitalOTHER | 1 | Sep 7, 2011 | clinicaltrials |
| NCT01417806 | Trial of pasireotideLAR and Topotecan in Relapsed or Refractory Small Cell Lung Cancer | unknown | Phase 2 | 28 | South Florida Veterans Affairs Foundation for Research and EducationFED | 1 | Aug 16, 2011 | clinicaltrials |
| NCT01402180 | Chemoradiation With or Without Nimotuzumab in Treating Esophageal Cancer Patients Who Suffer With Recurrence in Regional Lymph Nodes After Esophagectomy(Nimotuzumab) | unknown | Phase 2 / Phase 3 | 128 | Fudan UniversityOTHER | 1 | Jul 26, 2011 | clinicaltrials |
| NCT01391572 | A Trial Estimating The Optimal Radiation Volume Of Postsurgical Radiation For Patients With Esophageal Cancer | unknown | Phase 2 | 300 | Fudan UniversityOTHER | 1 | Jul 22, 2011 | clinicaltrials |
| NCT01236690 | Study of Hepatoma Treated by Perfusing Cinobufacin Through Hepatic Artery Combining Embolotherapy | unknown | Phase 2 | 284 | Changhai HospitalOTHER | 1 | Jun 28, 2011 | clinicaltrials |
| NCT01069770 | Neoadjuvant Sunitinib Treatment for Metastatic Clear Cell Renal Cell Carcinoma (RCC) | unknown | Phase 2 | 32 | Korean Urological Oncology SocietyOTHER | 1 | Jun 23, 2011 | clinicaltrials |
| NCT01170104 | Trial of Transcatheter Arterial Chemoembolization (TACE) With Sorafenib for Locally Advanced Hepatocellular Carcinoma (HCC) | unknown | Phase 2 | 63 | Chung-Ang UniversityOTHER | 1 | Jun 23, 2011 | clinicaltrials |
| NCT01377220 | Evaluation of 11 C-Choline PET-CT for Detection of Hepatocellular Carcinoma(CHOLPET) | unknown | Phase 2 | 30 | Commissariat A L'energie AtomiqueOTHER_GOV | 1 | Jun 21, 2011 | clinicaltrials |
| NCT01377298 | Pazopanib in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma | unknown | Phase 2 | 45 | National Taiwan University HospitalOTHER | 1 | Jun 21, 2011 | clinicaltrials |
| NCT01219751 | Trial Of Sunitinib In Advanced Non-Clear Cell Type Renal Cell Carcinoma | unknown | Phase 2 | 35 | Asan Medical CenterOTHER | 1 | Jun 17, 2011 | clinicaltrials |
| NCT01308645 | Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Primary Hepatocellular Carcinoma (HCC)(HCC) | unknown | Phase 2 | 30 | SBPharmaceutical IND, Co., LTDINDUSTRY | 1 | Jun 10, 2011 | clinicaltrials |
| NCT01336049 | Nimotuzumab Plus Paclitaxel and Cisplatin as 1st Line Treatment for Esophageal Squamous Cell Cancer | unknown | Phase 2 | 70 | Peking UniversityOTHER | 1 | Apr 15, 2011 | clinicaltrials |
| NCT01259193 | Clinical Study of Sorafenib and Zoledronic Acid to Treat Advanced HCC | unknown | Phase 2 | 50 | Fudan UniversityOTHER | 1 | Apr 14, 2011 | clinicaltrials |
| NCT00862303 | DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating Patients With Renal Cell Carcinoma | unknown | Phase 1 / Phase 2 | 100 | Fuzhou General HospitalOTHER | 1 | Mar 8, 2011 | clinicaltrials |
| NCT00178698 | Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors(FR-WB-TT/che) | unknown | Phase 2 | 36 | The University of Texas Health Science Center, HoustonOTHER | 1 | Mar 3, 2011 | clinicaltrials |
| NCT00990860 | Study in Asia of the Combination of TACE With Sorafenib in HCC Patients(START) | unknown | Phase 2 | 36 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Jan 5, 2011 | clinicaltrials |
| NCT00829192 | Phase II AK Study in Organ Transplant Patients | unknown | Phase 2 | 200 | Clinuvel Pharmaceuticals LimitedINDUSTRY | 7 | Dec 6, 2010 | clinicaltrials |
| NCT01240005 | Cytokine Induced Killer Cells Stimulated by DC Immunotherapy for Renal Cell Carcinoma | unknown | Phase 1 / Phase 2 | 30 | Qingdao UniversityOTHER | 1 | Nov 15, 2010 | clinicaltrials |
| NCT01203306 | Bevacizumab Plus Somatostatin Analogue and Metronomic Capecitabine in Patients With Advanced Neuroendocrine Tumors(XELBEVOCT) | unknown | Phase 2 | 42 | University of Turin, ItalyOTHER | 1 | Sep 16, 2010 | clinicaltrials |
| NCT01129154 | Panitumumab (Vectibix®) in Cutaneous Squamous Cell Carcinoma (SCC)(PASCE) | unknown | Phase 2 | 17 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | Aug 30, 2010 | clinicaltrials |
| NCT01175096 | Safety and Tolerability Profile of RAD001 Daily in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor | unknown | Phase 1 / Phase 2 | 20 | Guangdong Provincial People's HospitalOTHER | 1 | Aug 4, 2010 | clinicaltrials |
| NCT00561522 | Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection | unknown | Phase 2 / Phase 3 | 290 | Fudan UniversityOTHER | 1 | Jul 21, 2010 | clinicaltrials |
| NCT00610389 | Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid Tumors | unknown | Phase 2 | 27 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 1 | May 10, 2010 | clinicaltrials |
| NCT00707681 | Evaluation of Quality of Life and Survival With MS-20 in Patient With Advanced Hepatocellular Carcinoma (FDA IND 74572) | unknown | Phase 2 | 60 | Microbio Co LtdINDUSTRY | 1 | Feb 26, 2010 | clinicaltrials |
| NCT01055743 | The Effect of Fluorouracil Implants Regional Chemotherapy During the Surgical Treatment for Early Stage Hepatocellular Carcinoma | unknown | Phase 2 | 250 | Simcere Pharmaceutical Co., LtdOTHER | 1 | Jan 26, 2010 | clinicaltrials |
| NCT01041482 | A Multi-Center, Non-Controlled Clinical Study of Sorafenib Adjuvant Therapy in Advanced Renal-Cell Carcinoma(AGuo) | unknown | Phase 2 | 140 | Chinese Academy of Medical SciencesOTHER | 1 | Jan 6, 2010 | clinicaltrials |
| NCT00999843 | Safety Study of Sorafenib Following Combined Therapy of Radiation and TACE for Liver Cancer | unknown | Phase 1 / Phase 2 | 30 | Fudan UniversityOTHER | 1 | Oct 22, 2009 | clinicaltrials |
| NCT00740441 | A Phase II Study of AS1411 in Renal Cell Carcinoma | unknown | Phase 2 | 30 | Antisoma ResearchINDUSTRY | 1 | Sep 25, 2009 | clinicaltrials |
| NCT00960518 | TACE and Adefovir Compared With Transarterial Chemoembolization (TACE) Alone for Hepatitis B Virus (HBV)-Related Unresectable Hepatocellular Carcinoma (HCC)(TACE) | unknown | Phase 2 | 216 | Tongji UniversityOTHER | 1 | Aug 17, 2009 | clinicaltrials |
| NCT00390195 | Randomized Phase I/II of RAD001 in Advanced Hepatocellular Carcinoma (HCC) | unknown | Phase 1 / Phase 2 | 134 | National Health Research Institutes, TaiwanOTHER | 1 | Jul 2, 2009 | clinicaltrials |
| NCT00890110 | Autologous Vaccination of Stage 4 Renal Cell Carcinoma Combined With Sunitinib(rcc) | unknown | Phase 1 / Phase 2 | 13 | Hadassah Medical OrganizationOTHER | 0 | Apr 29, 2009 | clinicaltrials |
| NCT00786110 | Sorafenib Plus Paclitaxel in Adreno-Cortical-Cancer Patients(PAXO) | unknown | Phase 2 | 30 | University of Turin, ItalyOTHER | 1 | Feb 24, 2009 | clinicaltrials |
| NCT00844688 | Study of Sorafenib and Gemcitabine in Advanced Hepatocellular Carcinoma (HCC)(HCC) | unknown | Phase 2 | 30 | Combined Military Hospital, PakistanOTHER | 1 | Feb 16, 2009 | clinicaltrials |
| NCT00384800 | A Phase II Study of Tegafur/Uracil (UFUR®)Plus Thalidomide for the Treatment of Advanced or Metastatic Hepatocellular Carcinoma (HCC) | unknown | Phase 2 | 41 | Far Eastern Memorial HospitalOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00728078 | Low-Dose Thalidomide as Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma(LDT-RFA) | unknown | Phase 2 / Phase 3 | 200 | Sun Yat-sen UniversityOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00805896 | Songyou Granule and Transarterial Chemoembolization for Hepatocellular Carcinoma | unknown | Phase 2 | 260 | Fudan UniversityOTHER | 1 | Dec 31, 2008 | clinicaltrials |
| NCT00669747 | Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS) | unknown | Phase 2 | 45 | Windy Hill Medical, Inc.INDUSTRY | 1 | Oct 2, 2008 | clinicaltrials |
| NCT00752063 | Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular Carcinoma(SECOX) | unknown | Phase 2 | 52 | The University of Hong KongOTHER | 1 | Sep 15, 2008 | clinicaltrials |
| NCT00546130 | Feasibility Study of CDDP + CPT-11 + PSK for Extensive-Stage Disease (ED) Small Cell Lung Cancer(RNCLC) | unknown | Phase 2 | 45 | University of ToyamaOTHER | 1 | Sep 3, 2008 | clinicaltrials |
| NCT00652613 | Study of 3-Dimensional Conformal Radiotherapy (3D-CRT) Versus Intensity Modulated Radiotherapy (IMRT) for Head and Neck Squamous Cell Carcinoma (HNSCC) | unknown | Phase 2 | 60 | Tata Memorial HospitalOTHER_GOV | 1 | Apr 11, 2008 | clinicaltrials |
| NCT00384124 | Topical Imiquimod for Bowen's Disease of the Head and Neck | unknown | Phase 2 / Phase 3 | 50 | Brooke Army Medical CenterFED | 1 | Mar 26, 2008 | clinicaltrials |
| NCT00557713 | XELOX+Bevacizumab Followed by Capecitabine+Bevacizumab+Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma | unknown | Phase 2 | 44 | Associacio catalana per a la recerca oncologica i les seves implicacions sanitaries i socialsOTHER | 1 | Nov 14, 2007 | clinicaltrials |
| NCT00162669 | Bevacizumab in Advanced Hepatocellular Carcinoma | unknown | Phase 2 | 50 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 8, 2006 | clinicaltrials |
| NCT00356161 | HAI Via Interventionally Implanted Port Catheter Systems | unknown | Phase 2 | 100 | Charite University, Berlin, GermanyOTHER | 1 | Jul 25, 2006 | clinicaltrials |
Data updated 23 days agoSource updated Mar 28, 2012source: clinicaltrials